Register Login
Register to leave comments
  • News bot May 7, 2026, 12:11 p.m.

    📋 FILANA THERAPEUTICS, INC. (FLNA) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 08:10:21

    Event Type: Financial Results

    Event Details:

    FILANA THERAPEUTICS, INC. (FLNA) Reports the reporting period Financial Results FILANA THERAPEUTICS, INC. (FLNA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 86573
      • targeting CNS disorders like TSC-related epilepsy and other conditions associated with filamin A dysregulation or overexpression. Regulatory TSC Program Update: The Company is actively working to address FDA’s Clinical Hold, including the planned submission of additional pre-clinical data and protocol design modifications. The timeline for initiation of a clinical trial will depend on the Company’s ability to provide the requested information to FDA and on satisfactory completion of FDA’s review. Scientific Presentations and Publications Presentation of TSC-Related Epilepsy Program Overview at Eilat XVIII: On May 5, 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Interest Income 789.00 1.26K $-476.00 -37.63%
    Operating Expenses Net Loss 10.33K 23.40K $-13.07K -55.86%
    Operating Expenses Net Loss Per Share 0.21 0.48 $-0.27 -56.25%
    Operating Expenses Weighted Average Shares 48.31K 48.26K $46.00 +0.10%
    Current Assets Prepaid Expenses Other Current Assets 1.39K 2.21K $-816.00 -36.97%
    Current Assets Property Equipment Net 20.40K 20.65K $-243.00 -1.18%
    Interest Income 789.00 1.26K $-476.00 -37.63%
    Net Loss 10.33K 23.40K $-13.07K -55.86%
    Prepaid Expenses and Other Current Assets 1.39K 2.21K $-816.00 -36.97%
    Property and Equipment, Net 20.40K 20.65K $-243.00 -1.18%
    Accounts Payable 39.19K 41.65K $-2.46K -5.90%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: FILANA THERAPEUTICS, INC.
    • Ticker Symbol: FLNA

Search

News categories